Choosing a Korean Stem Cell Clinic — A 12-Point Confidence Checklist
Practical criteria for Thai patients selecting a Korean stem cell clinic: medical team, lab, price transparency, and follow-up.
By the StemCellSVF editorial team · 8 min read · published 2026-08-31 · research data auto-updated 17 August 2026
The short answer
A trustworthy Korean stem cell clinic names the treating physician and credentials, explains its cell processing in detail, gives an itemised quotation, measures outcomes before and after, and offers a follow-up plan once you are back in Thailand. If any point is unclear, keep asking until it is.
The medical team
- Know the treating physician's name and credentials in advance
- Is the assessment done by a doctor, not only a sales consultant?
- Experience with cases similar to yours
- English capability or a Thai interpreter fluent in medical terms
Lab and process
- Closed system that minimises contamination risk
- Cell count and viability testing
- Traceable processing records
- Clear timing between processing and use
Transparency of information and price
- A written, itemised quotation
- Explains both what research supports and what is still being studied
- No pressure tactics or expiring discounts
- Happy for you to take time and consult your own doctor
Cross-border follow-up
- Review points at 1, 3, and 6 months
- The same measures each time so results are comparable
- A remote channel that actually replies
- A summary a Thai physician can read and act on
Frequently asked questions
- How much weight should I give online reviews?
- Use them as one input, but weigh assessment quality, documentation, and plan clarity far more.
- Does it have to be a large hospital?
- Not necessarily — licensing, lab standards, and continuity of care matter more than size.
- Can I consult online first?
- Yes, and you should — it confirms suitability and avoids travelling for a plan that turns out unsuitable.
- What are the red flags?
- Guaranteed outcomes, rushed decisions, and refusal to provide written documentation.
Related articles
- The Real Cost Structure of Stem Cell Treatment in KoreaBreak down every cost component of stem cell care in Korea — consultation, cell processing, follow-up, plus travel and accommodation.
- Inside the Korean Lab — Cell Processing Standards Worth Asking AboutUnderstand cell processing, closed systems, quality testing, and traceability so you can judge clinic quality more accurately.
- 20 Questions to Ask a Korean Clinic Before You PayA ready-made question set for online consultations and in-person visits, covering plan, cells, pricing, and follow-up.
- Stem Cell Injections: What They Are and What Research ShowsWhat a stem cell injection involves, how the visit typically flows, and which benefits research is exploring — summarised from a live research database.
Research cited
Selected from 2 matching studies in our database · auto-updated 17 August 2026
- Level BClinical TrialPubMed
Study protocol for a randomized clinical trial evaluating the safety and efficacy of autologous adipose-derived stem cell therapy for ulcers in patients with critical limb ischemia.
Clinical Trial on Peripheral Artery Disease, published in PLoS One (2025) — summary generated from the PubMed abstract.
- 2025
PLoS One - Level BClinical TrialPubMed
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Clinical Trial with a reported sample of 18 on Systemic / IV, published in Neurosurg Pract (2023) — summary generated from the PubMed abstract.
- 2023
- n = 18
Neurosurg Pract6 citations
Newest research on this topic
Pulled live from 2 matching records, newest first (through 2026) — this block refreshes itself whenever new studies land, with no article rewrite.
- Level BClinical TrialPubMed
Study protocol for a randomized clinical trial evaluating the safety and efficacy of autologous adipose-derived stem cell therapy for ulcers in patients with critical limb ischemia.
Clinical Trial on Peripheral Artery Disease, published in PLoS One (2025) — summary generated from the PubMed abstract.
- 2025
PLoS One - Level BClinical TrialPubMed
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Clinical Trial with a reported sample of 18 on Systemic / IV, published in Neurosurg Pract (2023) — summary generated from the PubMed abstract.
- 2023
- n = 18
Neurosurg Pract6 citations
Keep exploring this topic
Search the research by this article's keywords
This article is educational and based on published research, not medical advice. Talk with a physician to plan what suits you.